1. The lncRNA PDIA3P Interacts with miR-185-5p to Modulate Oral Squamous Cell Carcinoma Progression by Targeting Cyclin D2
    Cheng-Cao Sun et al, 2017, Molecular Therapy - Nucleic Acids CrossRef
  2. MiR-155 Promotes Uveal Melanoma Cell Proliferation and Invasion by Regulating NDFIP1 Expression
    Jing Peng et al, 2017, Technol Cancer Res Treat CrossRef
  3. Inhibition of miR-155, a therapeutic target for breast cancer, prevented in cancer stem cell formation
    Jiangcheng Zuo et al, 2017, CBM CrossRef
  4. MiR-139-5p inhibits the tumorigenesis and progression of oral squamous carcinoma cells by targeting HOXA9
    Kai Wang et al, 2017, J. Cell. Mol. Med. CrossRef
  5. Effect of miR-29b on the Proliferation and Apoptosis of Pulmonary Artery Smooth Muscle Cells by Targeting Mcl-1 and CCND2
    Juan Chen et al, 2018, BioMed Research International CrossRef
  6. Invasion-Related Factors as Potential Diagnostic and Therapeutic Targets in Oral Squamous Cell Carcinoma—A Review
    Samadarani Siriwardena et al, 2018, IJMS CrossRef
  7. MiR-155-5p modulates HSV-1 replication via the epigenetic regulation of SRSF2 gene expression
    Ziqiang Wang et al, 2019, Epigenetics CrossRef
  8. Differential MicroRNA Expression of miR-21 and miR-155 within Oral Cancer Extracellular Vesicles in Response to Melatonin
    null Hunsaker et al, 2019, Dentistry Journal CrossRef
  9. MicroRNA expression patterns in oral squamous cell carcinoma: hsa‐mir‐99b‐3p and hsa‐mir‐100‐5p as novel prognostic markers for oral cancer
    Mark Jakob et al, 2019, Head & Neck CrossRef
  10. The short and the long: non-coding RNAs and growth factors in cancer progression.
    Aldema Sas-Chen et al, 2017, Biochem Soc Trans CrossRef
  11. MiR-155-5p promotes oral cancer progression by targeting chromatin remodeling gene ARID2
    Meng Wu et al, 2020, Biomedicine & Pharmacotherapy CrossRef
  12. Differential MicroRNA Signatures in the Pathogenesis of Barrettʼs Esophagus
    Michael P. Craig et al, 2020, Clinical and Translational Gastroenterology CrossRef
  13. Cyclin D Degradation by E3 Ligases in Cancer Progression and Treatment
    Shuo Qie et al, 2020, Seminars in Cancer Biology CrossRef
  14. Differential exosome miRNA expression in oral cancer stem cells
    M. Shoff et al, 2020, ExRNA CrossRef
  15. miR-185 inhibits prostate cancer angiogenesis induced by the nodal/ALK4 pathway.
    Youkong Li et al, 2020, BMC Urol CrossRef
  16. Promising landscape for regulating macrophage polarization: epigenetic viewpoint
    Dexi Zhou et al, 2017, Oncotarget CrossRef
  17. Exosome mediated miR-155 delivery confers cisplatin chemoresistance in oral cancer cells via epithelial-mesenchymal transition
    Prathibha Kirave et al, 2020, Oncotarget CrossRef
  18. Exosome-mediated delivery of miR-30a sensitize cisplatin-resistant variant of oral squamous carcinoma cells via modulating Beclin1 and Bcl2.
    Bhagyashri Kulkarni et al, 2020, Oncotarget CrossRef
  19. Noncoding RNAs in oral premalignant disorders and oral squamous cell carcinoma
    Fei Huang et al, 2020, Cell Oncol. CrossRef
  20. Ubiquitin‑specific peptidase 22 promotes proliferation and metastasis in human colon cancer
    Xiao Yuan et al, 2019, Oncol Lett CrossRef
  21. Overexpression of SMARCA2 or CAMK2D is associated with cisplatin resistance in human epithelial ovarian cancer
    Xiaoli Xu et al, 2018, Oncol Lett CrossRef
  22. The roles of microRNAs in the stemness of oral cancer cells
    Neslisah Barlak et al, 2020, Oral Oncology CrossRef
  23. Genetic alterations and clinical dimensions of oral cancer: a review
    Keerthana Karunakaran et al, 2020, Mol Biol Rep CrossRef
  24. microRNAs deregulation in head and neck squamous cell carcinoma
    Juliana Carron et al, 2020, Head & Neck CrossRef
  25. Regulators at Every Step—How microRNAs Drive Tumor Cell Invasiveness and Metastasis
    Tomasz M. Grzywa et al, 2020, Cancers CrossRef
  26. Exosome-derived microRNAs in oral squamous cell carcinomas impact disease prognosis
    Ching-Mei Chen et al, 2021, Oral Oncology CrossRef
  27. MiR-155 Inhibitor-Laden Exosomes Reverse Resistance to Cisplatin in a 3D Tumor Spheroid and Xenograft Model of Oral Cancer.
    Adil Ali Sayyed et al, 2021, Mol Pharm CrossRef
  28. null
    Qingxuan Lai et al, 2021 CrossRef
  29. MicroRNA-155-5p Contributes to 5-Fluorouracil Resistance Through Down-Regulating TP53INP1 in Oral Squamous Cell Carcinoma
    Bowen Liu et al, 2022, Front. Oncol. CrossRef